IDEX Corp. (NYSE: IEX) reported Q2 EPS of $2.06, $0.02 better than the analyst estimate of $2.04. Revenue for the quarter came in at $807 million versus the consensus estimate of $828.16 million.

GUIDANCE:

IDEX Corp. sees FY2024 EPS of $7.80-$7.90, versus the consensus of $8.29.
Full year organic sales growth is projected to decline 1% to 2% versus the prior year, down from previous guidance of an increase of 0% to 2%.

Third quarter organic sales are projected to be 0% to 1% over the prior year period
Third quarter GAAP diluted EPS of $1.61 - $1.66 (adjusted diluted EPS of $1.85 - $1.90, versus the consensus of $2.18.)

For earnings history and earnings-related data on IDEX Corp. (IEX) click here.